Novan's interim CEO outlines future focus

Novan ’s (Nasdaq: NOVN) interim CEO Kelly Martin – who is also CEO of Novan shareholder Malin Life Sciences Holding – said on an investor call Wednesday morning that strengthening Novan’s balance sheet is the most important focus in the near-term. Cash has continued to be a primary concern for Mo rrisville-based Novan in recent months, and the company has been struggling to regain footing following mixed Phase 3 trial results for its acne product SB204 that sent its stock plummeting 75 percent. As…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

Syneron Candela said today it won FDA clearance for a next-gen version of its Vbeam, the Vbeam Prima cosmetic laser designed to treat skin conditions. The newly cleared device is intended for use in treating skin conditions including rosacea, port wine stains, acne, facial, leg and spider veins, scars, benign pigmented lesions and wrinkles, warts, stretch marks and photo aging, the Wayland, Mass.-based company said. “In a clinical study using Vbeam Prima, facial redness and rosacea symptoms were dramatically reduced after 4 treatments. I’ve worked with the Vbeam platform for years, and I am extremely excited ab...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cosmetic/Aesthetic Food & Drug Administration (FDA) Regulatory/Compliance Syneron Medical Ltd. Source Type: news
Syneron Candela said today it won FDA clearance for a next-gen version of its Vbeam, the Vbeam Prima cosmetic laser designed to treat skin conditions. The newly cleared device is intended for use in treating skin conditions including rosacea, port wine stains, acne, facial, leg and spider veins, scars, benign pigmented lesions and wrinkles, warts, stretch marks and photo aging, the Wayland, Mass.-based company said. “In a clinical study using Vbeam Prima, facial redness and rosacea symptoms were dramatically reduced after 4 treatments. I’ve worked with the Vbeam platform for years, and I am extremely excited ab...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cosmetic/Aesthetic Food & Drug Administration (FDA) Regulatory/Compliance Syneron Medical Ltd. Source Type: news
Authors: Baldwin HE, Stein Gold LF, Gordon KB, Green JB, Leonardi CL, Sengelmann RD Abstract Updates on managing some of the most common dermatologic conditions for which patients seek care illuminated presentations at the Skin Disease Education Foundation's 42nd Annual Hawaii Dermatology Seminar®. This educational supplement summarizes the highlights of clinical sessions presented during this CME/CE conference. Treatment of psoriasis has continued to advance, with three interleukin (IL)-17 antagonists approved by the US Food and Drug Administration (FDA) and a fourth in phase 3 trials. An authority on the use ...
Source: Seminars in Cutaneous Medicine and Surgery - Category: Dermatology Tags: Semin Cutan Med Surg Source Type: research
In this study, psychiatric comorbidity and levels of self-inju...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Source: Journal of the European Academy of Dermatology and Venereology - Category: Dermatology Authors: Source Type: research
SUPPLEMENTS could be used to prevent some dry skin conditions, including eczema, psoriasis, acne and dandruff. Adding this cheap capsule to your diet everyday could lower your risk of dry skin symptoms.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
CONCLUSION: Topical 4HBAP (0.10%) significantly improves the appearance of fine lines and coarse wrinkles, reduces skin roughness, hyperpigmentation, facial erythema, and non-inflammatory acne lesions, and improves skin hydration without any observed side effects. J Drugs Dermatol. 2018;17(7):772-779. PMID: 30005100 [PubMed - in process]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
Conclusion. Administration of oral omega-3 in acne patients who are receiving isotretinoin decreases the mucocutaneous side effects of isotretinoin. This trial is registered with  IRCT201306238241N2. PMID: 30002675 [PubMed]
Source: Dermatology Research and Practice - Category: Dermatology Tags: Dermatol Res Pract Source Type: research
Authors: Xu D, Liu X, Lu C, Luo J, Wang C, Gao C, Xie J, Li X Abstract OBJECTIVES: Little is known about the roles of peripheral immune cell subsets in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome. Up to now, just a few studies have focused on this issue. We aimed to analyse the distribution and phenotype of T cell subsets and natural killer (NK) cells in the peripheral blood of patients with SAPHO syndrome. METHODS: The proportion and absolute counts of circulating immune cells were assessed in 19 patients diagnosed as SAPHO syndrome and 19 healthy controls. CD4+T cell subsets were a...
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research
Many home remedies can help people reduce their acne by treating oily skin, killing bacteria, and providing antioxidants. Natural treatments that reduce acne flare-ups include aloe vera gel, honey, and tea tree oil. Learn about 15 natural home remedies and how to use them to improve acne, pimples, and oily skin here.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Dermatology Source Type: news
More News: Acne | Health Management | Pharmaceuticals